Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 9Neoplasms 6Prostatic Neoplasms 5Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Lung Neoplasms 3Thyroid Neoplasms 2Lymphoma 2Communication 2Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Patient Preference 1Papillomavirus Infections 1Papillary Thyroid Microcarcinoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Motor Activity 1Melanoma 1Leukemia 1Hematologic Neoplasms 1Health Behavior 1HIV Infections 1Coitus 1Carcinoma, Transitional Cell 1Cancer Prevention 1

Interventions

Transurethral Resection of Prostate 1Focus Groups 1Ablation Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Papillary Thyroid Microcarcinoma × Focus Groups × Clear all
NCT01392222 2017-06-21

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

Memorial Sloan Kettering Cancer Center

Completed
21 enrolled
Head & Neck

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡